Cargando…

Identifying the Therapeutic and Prognostic Role of the CD8+ T Cell-Related Gene ALDH2 in Head and Neck Squamous Cell Carcinoma

Head and neck squamous cell carcinoma (HNSC) is a widely known malignancy which is usually diagnosed late and has a poor prognosis. This study focuses on finding a new gene linked with CD8+ T cell infiltration as a prognostic marker for patients with HNSC. Differential analysis of transcriptomic dat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hongmei, Li, Zhaozheng, Zheng, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772952/ https://www.ncbi.nlm.nih.gov/pubmed/36570380 http://dx.doi.org/10.1177/11769351221139252

Ejemplares similares

Prognostic and Therapeutic Potential of Nuclear Receptors in Head and Neck Squamous Cell Carcinomas
por: Knauer, Shirley K.
Publicado: (2009)

Prognostic Significance of CD4+ and CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Borsetto, Daniele, et al.
Publicado: (2021)

CD8(+) T-cell exhaustion in the tumor microenvironment of head and neck squamous cell carcinoma determines poor prognosis
por: Zhang, Yijian, et al.
Publicado: (2022)

Protein methyltransferases and demethylases dictate CD8+ T-cell exclusion in squamous cell carcinoma of the head and neck
por: Vougiouklakis, Theodore, et al.
Publicado: (2017)

CD244 represents a new therapeutic target in head and neck squamous cell carcinoma
por: Agresta, Laura, et al.
Publicado: (2020)

SEC61G identified as a prognostic biomarker of head and neck squamous cell carcinoma
por: Shi, Yanan, et al.
Publicado: (2021)

Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
por: Liu, Shuo, et al.
Publicado: (2022)

Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8 (+) T cells
por: Wang, Mengyao, et al.
Publicado: (2023)

Identification of Therapeutic and Prognostic Biomarkers of Lamin C (LAMC) Family Members in Head and Neck Squamous Cell Carcinoma
por: Jiang, Pan, et al.
Publicado: (2020)

Intratumoral CD103(+)CD8(+) T cells predict response to neoadjuvant chemoimmunotherapy in advanced head and neck squamous cell carcinoma
por: Ren, Siqi, et al.
Publicado: (2023)

Multiomics Integrative Analysis Identifying EPC1 as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma
por: Dai, Yongmei, et al.
Publicado: (2022)

Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
por: Bossi, Paolo, et al.
Publicado: (2016)

Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma
por: Magnes, Teresa, et al.
Publicado: (2021)

The prognostic impact of the immune signature in head and neck squamous cell carcinoma
por: Baysal, Hasan, et al.
Publicado: (2022)

The prognostic role of PSMD14 in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2022)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma
por: Yao, Yao, et al.
Publicado: (2020)

Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck
por: Boucek, Jan, et al.
Publicado: (2010)

Effector CD8(+)CD45RO(−)CD27(−)T cells have signalling defects in patients with squamous cell carcinoma of the head and neck
por: Kuss, I, et al.
Publicado: (2003)

Association of ALDH1 with Response to Radiotherapy and Its Impact on Survival in Patients with Advanced Stage of Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Dubey, Parul, et al.
Publicado: (2022)

The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma
por: Wilson, Harper L., et al.
Publicado: (2020)

Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma
por: Liu, Maohua, et al.
Publicado: (2023)

Comprehensive analysis of transcriptome data for identifying biomarkers and therapeutic targets in head and neck squamous cell carcinoma
por: Jin, Yu, et al.
Publicado: (2020)

Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma
por: Wu, Yaping, et al.
Publicado: (2019)

Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma—A Review
por: Devaraja, K., et al.
Publicado: (2023)

Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma
por: Shen, Ao, et al.
Publicado: (2022)

Prognostic Value of CD200R1 mRNA Expression in Head and Neck Squamous Cell Carcinoma
por: Chang, Hyun, et al.
Publicado: (2020)

Prognostic value of CD247 in patients with head and neck squamous cell carcinoma: bioinformatic analysis of TCGA database
por: Lin, Peng, et al.
Publicado: (2022)

CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma
por: Fukusumi, T, et al.
Publicado: (2014)

Characterization of CD44 variant expression in head and neck squamous cell carcinomas
por: Spiegelberg, D., et al.
Publicado: (2013)

Expression of CD44 in Head and Neck Squamous Cell Carcinoma—An In-Silico Study
por: Kavitha, Loganathan, et al.
Publicado: (2023)

Data Mining Identifies Six Proteins that Can Act as Prognostic Markers for Head and Neck Squamous Cell Carcinoma
por: Wu, Zeng-hong, et al.
Publicado: (2020)

Identifying Oxidized Lipid Metabolism-Related LncRNAs as Prognostic Biomarkers of Head and Neck Squamous Cell Carcinoma
por: Zhang, Ziwei, et al.
Publicado: (2023)

Identify and validate circadian regulators as potential prognostic markers and immune infiltrates in head and neck squamous cell carcinoma
por: Jin, Yi, et al.
Publicado: (2023)

ADAM8 in squamous cell carcinoma of the head and neck: a retrospective study
por: Zielinski, Valerie, et al.
Publicado: (2012)

Prognostic value of FDG PET/CT in head and neck squamous cell carcinomas
por: Dequanter, D, et al.
Publicado: (2015)

Prognostic factors of cervical node status in head and neck squamous cell carcinoma
por: Burusapat, Chairat, et al.
Publicado: (2015)

LTBP2 is a prognostic marker in head and neck squamous cell carcinoma
por: Han, Liang, et al.
Publicado: (2016)

The prognostic significance of estrogen receptor β in head and neck squamous cell carcinoma
por: Grsic, Kresimir, et al.
Publicado: (2016)

Alteration status and prognostic value of MET in head and neck squamous cell carcinoma
por: Cho, Yoon Ah, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_18jbre2oj693mkeffr1seasri5